Epidemiology of Cefotaxime-Hydrolysing β-Lactamase-Producing Escherichia coli in Children with Diarrhoea Reported Globally between 2012 and 2022
-
Published:2024-01-15
Issue:1
Volume:12
Page:171
-
ISSN:2076-2607
-
Container-title:Microorganisms
-
language:en
-
Short-container-title:Microorganisms
Author:
Karambwe Simbarashe1ORCID, Traoré Afsatou Ndama1ORCID, Potgieter Natasha1ORCID
Affiliation:
1. Department of Biochemistry and Microbiology, University of Venda, Private Bag X5050, Thohoyandou 0950, South Africa
Abstract
The global spread of cefotaxime-hydrolysing β-lactamase (CTX-M)-producing Escherichia coli (E. coli) and its associated impact on paediatric diarrhoeal treatment and management has become a public health concern. This review assessed surveillance studies on CTX-M-producing E. coli associated with diarrhoea in children published between 2012 and 2022 globally. A total of thirty-eight studies were included for data analysis, categorised into continental regions, and tabulated. The majority (68%) of studies were conducted in Asian countries while few studies were conducted in Europe (11%) and Africa (18%), respectively. On the African continent, the majority (11%) of studies were conducted in Northern Africa while no studies were reported in East Africa. On the American continent, 3% of the studies were reported from South America. The studies included were classified into diarrheagenic E. coli (74%; 28/38) and faecal carriage (26%; 10/38). Of all the E. coli pathotypes associated with CTX-M production, EPEC was frequently reported. The prevalence of CTX-M-producing E. coli including the CTX-M-15-producing variants ranged between 1% and 94%. About 37% of the studies generalised the report as blaCTX-M-positive E. coli. The use of sequencing in characterising the CTX-M-producing E. coli was reported in only 32% of all the studies. This review provides information on the epidemiology of CTX-M-15-producing E. coli in paediatric diarrhoea and the extent to which surveillance is being performed. This is relevant in informing clinical practice for the management of diarrhoea as well as the design of future surveillance studies.
Subject
Virology,Microbiology (medical),Microbiology
Reference64 articles.
1. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: Asystematic analysis for the Global Burden of Disease Study 2016;Troeger;Lancet Infect. Dis.,2018 2. Genotypic and phenotypic study of E. coli isolated from children suffering from severe diarrhea with some antibiotic resistant gene;Hamad;World J. Adv. Res. Rev.,2022 3. Zhou, Y., Zhu, X., Hou, H., Lu, Y., Yu, J., Mao, L., Mao, L., and Sun, Z. (2018). Characteristics of diarrheagenic Escherichia coli among children under 5 years of age with acute diarrhea: A hospital-based study. BMC Infect. Dis., 18. 4. Memariani, M., Peerayeh, S.N., Salehi, T.Z., and Mostafavi, S.K.S. (2015). Occurrence of SHV, TEM and CTX-M β-Lactamase Genes among Enteropathogenic Escherichia coli Strains Isolated from Children with Diarrhea. Jundishapur J. Microbiol., 8. 5. Salleh, M.Z., Zuraina, N.M.N.N., Hajissa, K., Ilias, M.I., and Deris, Z.Z. (2022). Prevalence of Multidrug-Resistant Diarrheagenic Escherichia coli in Asia: A Systematic Review and Meta-Analysis. Antibiotics, 11.
|
|